Contact this trialFirst, we need to learn more about you.
IDH1 Inhibitor
Ivosidenib for Chondrosarcoma
Recruiting1 awardPhase 3
Jacksonville, Florida
This trial is testing a drug called ivosidenib for the treatment of a specific type of bone cancer called chondrosarcoma. Participants must have a certain gene mutation and advanced stage of the
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service